BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Shi Y, Song Y, Sun X, Zhang X, Sun K, Li Y. The use of low molecular weight protamine to enhance oral absorption of exenatide. Int J Pharm 2018;547:265-73. [PMID: 29800739 DOI: 10.1016/j.ijpharm.2018.05.055] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hedin KA, Zhang H, Kruse V, Rees VE, Bäckhed F, Greiner TU, Vazquez-uribe R, Sommer MOA. Oral delivery of GLP-1R agonist by an engineered probiotic yeast strain has anti-obesity effects in mice.. [DOI: 10.1101/2022.12.21.521368] [Reference Citation Analysis]
2 Choy C, Lim LY, Chan LW, Cui Z, Mao S, Wong TW, Page C. Exploring Intestinal Surface Receptors in Oral Nanoinsulin Delivery. Pharmacol Rev 2022;74:960-81. [DOI: 10.1124/pharmrev.122.000631] [Reference Citation Analysis]
3 Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621 [DOI: 10.4239/wjd.v13.i8.613] [Reference Citation Analysis]
4 Zhang J, Liu X, Lin J, Bao X, Peng J, Gong Z, Luan X, Chen Y. Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121979] [Reference Citation Analysis]
5 Peng S, Song H, Chen Y, Li S, Guan X. Oral Delivery of Food-derived Bioactive Peptides: Challenges and Strategies. Food Reviews International. [DOI: 10.1080/87559129.2022.2062772] [Reference Citation Analysis]
6 Bendicho-Lavilla C, Seoane-Viaño I, Otero-Espinar FJ, Luzardo-Álvarez A. Fighting type 2 diabetes: Formulation strategies for peptide-based therapeutics. Acta Pharm Sin B 2022;12:621-36. [PMID: 35256935 DOI: 10.1016/j.apsb.2021.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liang Y, Ding R, Wang H, Liu L, He J, Tao Y, Zhao Z, Zhang J, Wang A, Sun K, Li Y, Shi Y. Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption. Drug Delivery 2022;29:305-15. [DOI: 10.1080/10717544.2021.2023704] [Reference Citation Analysis]
8 Arora M, Zou D, Ravi Kumar M. Nanoparticle-assisted oral delivery of small and large peptides. Oral Delivery of Therapeutic Peptides and Proteins 2022. [DOI: 10.1016/b978-0-12-821061-1.00007-1] [Reference Citation Analysis]
9 Ren Y, Wang X, Liang H, He W, Zhao X. Mechanism of miR-30b-5p-Loaded PEG-PLGA Nanoparticles for Targeted Treatment of Heart Failure. Front Pharmacol 2021;12:745429. [PMID: 34658880 DOI: 10.3389/fphar.2021.745429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B 2021;11:2416-48. [PMID: 34522593 DOI: 10.1016/j.apsb.2021.04.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
11 Han Y, Liu W, Chen L, Xin X, Wang Q, Zhang X, Jin M, Gao Z, Huang W. Effective oral delivery of Exenatide-Zn2+ complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy. Biomaterials 2021;275:120944. [PMID: 34153783 DOI: 10.1016/j.biomaterials.2021.120944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Fu Y, Ding Y, Zhang L, Zhang Y, Liu J, Yu P. Poly ethylene glycol (PEG)-Related controllable and sustainable antidiabetic drug delivery systems. Eur J Med Chem 2021;217:113372. [PMID: 33744689 DOI: 10.1016/j.ejmech.2021.113372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
13 Eissa NG, Elsabahy M, Allam A. Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs. Int J Pharm 2021;597:120317. [PMID: 33540005 DOI: 10.1016/j.ijpharm.2021.120317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Xu G, Bao X, Yao P. Protamine and BSA-dextran complex emulsion improves oral bioavailability and anti-tumor efficacy of paclitaxel. Drug Deliv 2020;27:1360-8. [PMID: 32985911 DOI: 10.1080/10717544.2020.1825543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
15 Tan X, Yin N, Liu Z, Sun R, Gou J, Yin T, Zhang Y, He H, Tang X. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin. Mol Pharmaceutics 2020;17:3177-91. [DOI: 10.1021/acs.molpharmaceut.0c00223] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
16 Ismail R, Phan TNQ, Laffleur F, Csóka I, Bernkop-schnürch A. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery. European Journal of Pharmaceutics and Biopharmaceutics 2020;152:10-7. [DOI: 10.1016/j.ejpb.2020.04.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
17 Robla S, Alonso MJ, Csaba NS. Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery. Expert Opinion on Drug Delivery 2020;17:1081-92. [DOI: 10.1080/17425247.2020.1776698] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Song Y, Shi Y, Zhang L, Hu H, Zhang C, Yin M, Zhang X, Sun K. Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency. Nanomedicine (Lond) 2019;14:989-1009. [PMID: 31088322 DOI: 10.2217/nnm-2018-0322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
19 Han Y, Gao Z, Chen L, Kang L, Huang W, Jin M, Wang Q, Bae YH. Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins. Acta Pharm Sin B 2019;9:902-22. [PMID: 31649842 DOI: 10.1016/j.apsb.2019.01.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 14.3] [Reference Citation Analysis]
20 Kaldybekov DB, Filippov SK, Radulescu A, Khutoryanskiy VV. Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery. Eur J Pharm Biopharm 2019;143:24-34. [PMID: 31419584 DOI: 10.1016/j.ejpb.2019.08.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
21 Mahmood A, Bernkop-Schnürch A. SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev 2019;142:91-101. [PMID: 29981355 DOI: 10.1016/j.addr.2018.07.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
22 Pinho AR, Fortuna A, Falcão A, Santos AC, Seiça R, Estevens C, Veiga F, Ribeiro AJ. Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices. J Pharm Anal 2019;9:143-55. [PMID: 31297291 DOI: 10.1016/j.jpha.2019.02.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
23 Song Y, Shi Y, Zhang L, Hu H, Zhang C, Yin M, Chu L, Yan X, Zhao M, Zhang X, Mu H, Sun K. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption. Mol Pharm 2019;16:518-32. [PMID: 30601014 DOI: 10.1021/acs.molpharmaceut.8b00809] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 12.3] [Reference Citation Analysis]
24 Wong CY, Al-salami H, Dass CR. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus. International Journal of Pharmaceutics 2018;549:201-17. [DOI: 10.1016/j.ijpharm.2018.07.041] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 10.6] [Reference Citation Analysis]